If you’ve been on this planet for 70 years, you would have been present for four global recessions. The first would have been in 1975, and the last in 2009. The flames of warning are starting to flicker again says Reuters – higher interest rates, red-hot inflation, and energy crisis – and of course the coming food crisis we covered recently. Retail investors need to take a holistic look at what risks they’re currently taking (threats) and what quality companies might be purchased on the cheap (opportunities) as the market wallows in misery.
Our approach is to find a compelling thesis and invest in the market leader, something usually measured by market cap and revenues. The bigger the company, the more they enjoy economies of scale. The faster revenues grow, the quicker market share is being captured. That’s how we describe “best.” Today, we’re going to look for “the best” of seven proteomics stocks which provide exposure to the burgeoning life sciences field of protein engineering..
Seven Proteomics Stocks